Physician Wealth Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Physician Wealth Advisors’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10	Closed	-$528	–	2450
2026 Q1	$528	Buy	+10	New	+$411	﹤0.01%	1906

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Physician Wealth Advisors's TERN Position: Q2 2026 in Review

Physician Wealth Advisors sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 10 shares — an estimated $528 sold.

Physician Wealth Advisors first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $528 in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Physician Wealth Advisors reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Physician Wealth Advisors sold 10 Terns Pharmaceuticals shares in Q2 2026, an estimated $528.
Physician Wealth Advisors first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Physician Wealth Advisors's Terns Pharmaceuticals position peaked at $528 in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.